Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

NCT00016926 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: capecitabine

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]